Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hermle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Topics in Behavioral Neurosciences|April 27, 2017
Experimental Psychosis Research and Schizophrenia-Similarities and Dissimilarities in PsychopathologyLeo Hermle, Rainer Kraehenmann
Therapeutic Advances in Psychopharmacology|August 29, 2013
Hallucinogen-persisting perception disorderLeo Hermle, Melanie Simon, Martin Ruchsow, et al.
Schizophrenia Research|September 1, 2009
Increased unconscious semantic activation in schizophrenia patients with formal thought disorderMarkus Kiefer, Ulla Martens, Matthias Weisbrod, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 27, 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic reviewSimon Reiche, Leo Hermle, Stefan Gutwinski, et al.
Fortschritte Der Neurologie-Psychiatrie|August 3, 2017
[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]Tomislav Majić, Henrik Jungaberle, Timo T Schmidt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 9, 2003
Enantioselective quantitation of the ecstasy compound (R)- and (S)-N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma and urineJochen Buechler, Matthias Schwab, Gerd Mikus, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Risperidone monotherapy in manic inpatients: an open label, multicentre trialAnna Forsthoff, Heinz Grunze, Florian Seemüller, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Topics in Behavioral Neurosciences|April 27, 2017
Experimental Psychosis Research and Schizophrenia-Similarities and Dissimilarities in PsychopathologyLeo Hermle, Rainer Kraehenmann
Therapeutic Advances in Psychopharmacology|August 29, 2013
Hallucinogen-persisting perception disorderLeo Hermle, Melanie Simon, Martin Ruchsow, et al.
Schizophrenia Research|September 1, 2009
Increased unconscious semantic activation in schizophrenia patients with formal thought disorderMarkus Kiefer, Ulla Martens, Matthias Weisbrod, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 27, 2017
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic reviewSimon Reiche, Leo Hermle, Stefan Gutwinski, et al.
Fortschritte Der Neurologie-Psychiatrie|August 3, 2017
[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]Tomislav Majić, Henrik Jungaberle, Timo T Schmidt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 9, 2003
Enantioselective quantitation of the ecstasy compound (R)- and (S)-N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma and urineJochen Buechler, Matthias Schwab, Gerd Mikus, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Risperidone monotherapy in manic inpatients: an open label, multicentre trialAnna Forsthoff, Heinz Grunze, Florian Seemüller, et al.
Pageof 1